RecruitingNCT00272883

Molecular and Genetic Studies of Congenital Myopathies

Molecular Analysis of Neuromuscular Disease


Sponsor

Boston Children's Hospital

Enrollment

4,000 participants

Start Date

Aug 1, 2003

Study Type

OBSERVATIONAL

Conditions

Summary

In the Congenital Myopathy Research Program at Boston Children's Hospital and Harvard Medical School, the researchers are studying the congenital myopathies (neuromuscular diseases present from birth), including central core disease, centronuclear/myotubular myopathy, congenital fiber type disproportion, multiminicore disease, nemaline myopathy, rigid spine muscular dystrophy, SELENON (SEPN1), RYR1 myopathy, ADSS1 (ADSSL) Myopathy and undefined congenital myopathies. The primary goal of the research is to better understand the genes and proteins (gene products) involved in muscle functioning and disease. The researchers hope that our studies will allow for improved diagnosis and treatment of individuals with congenital myopathies in the future. For more information, visit the Laboratory Website at www.childrenshospital.org/research/beggs


Eligibility

Inclusion Criteria1

  • Individuals with a clinical or suspected diagnosis of a congenital myopathy and their family members

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Genetics Division, Boston Children's Hospital

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00272883


Related Trials